StonvexLoading…
StonvexStonvexStonvexCore line items from INTU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $17.09B | $8.54B | $3.88B | $18.83B |
Operating Income | $5.41B | $1.39B | $534.00M | $4.92B |
Net Income | $4.20B | $1.14B | $446.00M | $3.87B |
EPS (Diluted) | $15.05 | $4.06 | $1.59 | $13.67 |
Total Assets | $39.33B | $34.28B | $33.19B | $36.96B |
Total Liabilities | $18.70B | $15.23B | $13.87B | $17.25B |
Cash & Equivalents | $4.68B | $2.94B | $3.51B | $2.88B |
Free Cash Flow OCF − CapEx | $7.36B | $2.12B | $599.00M | $6.12B |
Shares Outstanding | 279.00M | 281.00M | 281.00M | 279.13M |